Drug intelligence / Profile preview

FL7736

Development stage
Preclinical
Lead developer
Canget BioTekpharma
Modality
Small Molecules
01

Overview

FL7736 is a small molecule antineoplastic agent being developed by Canget BioTekpharma as a back-up compound to the lead candidate FL118, specifically for the treatment of prostate cancer. Its mechanism of action, shared with the FL118 platform, involves targeting the DEAD-box helicase 5 (DDX5/p68) and downregulating the expression of several key anti-apoptotic proteins, including survivin, Mcl-1, XIAP, and cIAP2, as well as mutant Kras (mKras). By inhibiting these critical survival and resistance factors, FL7736 is designed to overcome drug resistance and induce apoptosis in cancer cells. The compound is currently in the preclinical stage of development.

02

Targets

MCL1 (Myeloid cell leukemia sequence 1)XIAP (Baculoviral IAP repeat-containing protein 4)DDX5 (Phosphorylated-p68 RNA helicase)BIRC3 (Baculoviral IAP repeat-containing protein 3)KRAS (Kirsten rat sarcoma viral oncogene homolog)

Beyond the preview

Go deeper on FL7736.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FL7736.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call